Home › Non-Muscle Invasive Bladder Cancer › Florida
Non-Muscle Invasive Bladder Cancer clinical trials in Florida
15 studies for Non-Muscle Invasive Bladder Cancer are looking for participants at sites in Florida.
Cities in Florida
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
- Urological Research Network ( Site 0133), Hialeah
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06833073A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
- Moffitt Cancer Center at SouthShore, Ruskin
- Moffitt Cancer Center - International Plaza, Tampa
- Moffitt Cancer Center - McKinley Campus, Tampa
- and 3 more
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07206225A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
- Advanced Urology Institute, Largo
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06919965A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
- Florida Urology Partners, Wimauma
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07309445Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
- Bay Pines VA Healthcare System, Bay Pines
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT05796375A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer
- Moffitt Cancer Center, Tampa
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT06503614Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy
- Moffitt Cancer Center, Tampa
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07144319A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)
- Moffitt Cancer Center ( Site 0057), Tampa
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 28, 2026 · NCT06637423Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
- Mayo Clinic, Jacksonville
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT05951179FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- Advent Health, Orlando
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT05614739LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- University of Florida, Jacksonville
- Sylvester Comprehensive Cancer Center / University of Miami Hospital and Clinics, Miami
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 7, 2026 · NCT04752722Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
- UF Health Cancer Institute - Gainesville, Gainesville
- Mayo Clinic in Florida, Jacksonville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 5, 2026 · NCT07000084Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
- H. Lee Moffitt Cancer Center & Research Institute, Tampa
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT07225127A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
- Advanced Urology Institute, Daytona Beach
- University of Florida, Gainesville
- Advent Health, Orlando
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated May 27, 2026 · NCT05710848In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial
- Mayo Clinic in Florida, Jacksonville
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Mar 30, 2026 · NCT06704191From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.